Bharat Book Bureau Provides the Trending Market Research Report on “Global Gynecology Drugs Market, By Therapeutics (Non-Hormonal Therapy vs. Hormonal Therapy), By Indication (Contraception, Gynecology Infections, Female Infertility, Postmenopausal disorders, Polycystic Ovary Syndrome, Osteoporosis, Gynecology Cancer, Endometriosis, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2027 ” under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence, and Market reports.

The Global Gynecology Drugs Market was valued at USD14139.56 million in 2021 and is expected to grow at a steady CAGR of 8.64% in the forecast period, 2023-2027, to reach USD21395.67 million by 2027. The market is driven by the increased incidences of gynecological diseases and the rise in the elderly female population. Also, the high-end investments by the public and private players in research and development activities to improve the effectiveness of drugs and eliminate the side effects are expected to create lucrative growth opportunities for the global gynecology drugs market in the forecast period.
The rise in the female old age population is expected to fuel the demand for gynecology drugs as they are more prone and are at higher risk of getting affected by gynecological disorders. According to the World Population Prospects in 2021, about 9.5% of females above the age group of 60 years are vulnerable to getting affected by gynecological disorders. The growing old-age population is expected to fuel the demand for the global gynecology drugs market in the forecast period.


The global gynecology drugs market is segmented into therapeutics, indication, distribution channel, regional distribution, and competitive landscape. Based on regional distribution, the North American region dominated the market in 2021 and held 35.09% of the overall market share. The presence of major market players and well-developed healthcare infrastructure are the primary drivers for the gynecology drugs market. Also, the increased prevalence of breast cancer, menopausal disorders, busy lifestyles, and high stress in women is accelerating the demand for gynecology drugs.
Major companies operating in the global gynecology market are Amgen Inc., F. Hoffmann La Roche Ltd., Novartis AG, Bayer AG, Merck & Co., Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, AbbVie Inc., GlaxoSmithKline Plc, AstraZeneca Plc, Lupin Limited, Johnson and Johnson, Sanofi SA, Ferring Pharmaceuticals, amongst others.

Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2023-2027

Objective of the Study:
•To analyze the historical growth and the market size of the global gynecology drugs market from 2017 to 2021.
•To estimate and forecast the market size of the global gynecology drugs market from 2023 to 2027 and growth rate until 2027.
•To classify and forecast the global gynecology drugs market is divided into therapeutics, indication, distribution channel, regional distribution, and competitive landscape.
•To identify drivers and challenges for the global gynecology drugs market.
•To examine competitive developments such as expansions, new product launches, mergers, and acquisitions, etc., in the global gynecology drugs market.
•To conduct pricing analysis for the global gynecology drugs market.
•To identify and analyze the profile of leading players operating in global gynecology drugs market.

Our Research performed both primary as well as exhaustive secondary research for this study. Initially, our research sourced a list of leading gynecology drugs manufacturers across the globe. Subsequently, our research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, our research could include the gynecology drugs manufacturers who could not be identified due to the limitations of secondary research. Our research analyzed the gynecology drugs manufacturers, distribution channels and presence of all major players operating in the global gynecology drugs market all over the world.
Our research calculated the global gynecology drugs market size using a bottom-up approach, where data for various regions was recorded and forecasted for the future years. Our research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by our research.

Key Target Audience:
•Gynecology drugs manufacturers/ suppliers/ distributors
•Government bodies such as regulating authorities and policy makers
•Organizations, forums, and alliances related to gynecology drugs
•Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for industry stakeholders such as gynecology drugs manufacturers, suppliers, distributors, and other stakeholders. The report would enable the stakeholders in strategizing investments and capitalizing on emerging market opportunities.

Report Scope:
In this report, global gynecology drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Gynecology Drugs Market, By Therapeutics:
oNon-Hormonal Therapy
oHormonal Therapy
•Gynecology Drugs Market, By Indication:
oContraception
oGynecology Infections
oFemale Infertility
oPostmenopausal disorders
oPolycystic Ovary Syndrome
oOsteoporosis
oGynecology Cancers
oEndometriosis
oOthers (Urogenital Malformation, UTI & others)
•Gynecology Drugs Market, By Distribution Channel:
oRetail Pharmacies
oHospital Pharmacies
oOnline Pharmacies
•Gynecology Drugs Market, By Region:
oNorth America
§United States
§Canada
§Mexico
oEurope
§Germany
§France
§United Kingdom
§Italy
§Spain
oAsia-Pacific
§China
§Japan
§India
§Australia
§South Korea
oSouth America
§Brazil
§Argentina
§Colombia
oMiddle East & Africa
§South Africa
§Saudi Arabia
§UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global gynecology drugs market.

Available Customizations:
With the given market data, our research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Browse our full report with Table of Content :

https://www.bharatbook.com/report/1358707/global-gynecology-drugs-market-by-therapeutics-non-hormonal-therapy-vs-hormonal-therapy-by-indication-contraception-gynecology-infections-female-infertility-postmenopausal-disorders-polycystic-ovary-syndrome-osteoporosis-gynecology-cancer-endometriosis-others-by-distribution-channel-retail-pharmacies-hospital-pharmacies-online-pharmacies-by-region-competition-forecast-opportunities

About Bharat Book Bureau:
Bharat Book is Your One-Stop-Shop with an exhaustive coverage of 15,00,000 reports and insights that includes the latest Market Study, Market Trends & Analysis, Forecasts Customized Intelligence, Newsletters, and Online Databases. Overall a comprehensive coverage of major industries with a further segmentation of 100+ subsectors.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email: [email protected]
Website: www.bharatbook.com